- CConnexion
RééDOC
75 Boulevard Lobau 54042 NANCY cedex Christelle Grandidier Documentaliste 03 83 52 67 64 0
|
Pharmacologic management of the spastic and dystonic upper limb in children with cerebral palsy
O'FLAHERTY S; WAUGH MC
HAND CLIN , 2003, vol. 19, n° 4, p. 585-589 Doc n°: 110973 Descripteurs : DD16 - TRAITEMENTS - MEMBRE SUPERIEUR, AJ23 - PARALYSIE CEREBRALE Pharmacologic management in cerebral palsy may be directed to spasticity, dystonia, or a combination of these after an assessment of treatment goals. The most common pharmacologic agents are botulinum toxin (discussed elsewhere) for spasticity and dystonia, baclofen, diazepam, dantrolene sodium, and tizanidine for spasticity, and L-Dopa and benzhexol for dystonia. Medications are introduced slowly to monitor efficacy and side effects and are performed largely on an open trial basis, as evidence of specific treatment programs is lacking. Langue : ANGLAIS Identifiant basis : 2004229040 |
0
|